A Mini Review and Implementation Model for Using Ataluren to Treat Nonsense Mutation Duchenne Muscular Dystrophy

Acta Paediatrica, International Journal of Paediatrics - United States
doi 10.1111/apa.14568
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/ Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)

Journal of Child Neurology
Child HealthNeurologyPediatricsPerinatology
2010English

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy

2020English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Improved Mouse Model for Studying Duchenne Muscular Dystrophy (DMD)

Science-Business eXchange
2010English

Emerging Drugs for Duchenne Muscular Dystrophy

Expert Opinion on Emerging Drugs
Pharmacology
2012English

Gene Therapy for Duchenne Muscular Dystrophy

Archives of Neurology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy